TRANSPLANTATION OF UNRELATED UMBILICAL CORD BLOOD TO CORRECT GENETIC DISEASES IN PEDIATRIC PATIENTS Kurtzberg, J.; Howrey, R.P.; Szabolcs, P.M.; Driscoll, T.A.; Ciocci, G.; Wood, S.; Stevens, C.E.; Rubinstein,P.; Martin,P.L.REASSESSMENT OF ABO-INCOMPATIBILITY IN HEMATOPOIETIC STEM CELL TRANSPLANTATION Stussi, G.; Muntwyler, J.; Seebach, L.; Passweg, J.; Schanz, U.; Gratwohl, A.; Gmur, J.; Seebach, J.DECREASED TRANSPLANT RELATED MORTALITY AFTER THYMOGLOBULINE CONDITIONING BEFORE BONE MARROW TRANSPLANTATION USING UNRELATED DONORS. RESULTS FROM A MATCHED COHORT STUDY Remberger, M.; Storer, B.; Ringden, O.; Anasetti, C.IMMUNE RECONSTITUTION AFTER ALLOGENEIC MARROW VERSUS BLOOD STEM CELL TRANSPLANTATION Storek, J.; Dawson, M.A.; Storer, B.; Stevens-Ayers, T.; Maloney, D.G.; Boeckh, M.QUALITY OF LIFE AND SEXUAL LIFE IN PATIENTS POST HEMATOPOIETIC STEM CELL TRANSPLANTATION Park, E.; Lee, M.H.; Yoon, S.S.; Kim, W.S.; Park, C.SYNGENEIC STEM CELL TRANSPLANTATION FOR METASTATIC BREAST CANCER Williams, S.; Rizzo, D.; Wu, J.; Antman,K.